Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension

Inclusion Criteria:

• 18 years or older.

• Ocular Surface Disease Index (OSDI) score and corneal fluorescein staining score asspecified in protocol.

• Diagnosis of open-angle glaucoma or ocular hypertension in at least one eye.

• Intraocular pressure (IOP) controlled with latanoprost 0.005% (XALATAN®) for at leastone continuous month prior to Visit 1.

• Willing and able to discontinue use of any topical ocular medication other than thestudy medication for the duration of the study, including artificial tears.

• Best corrected visual acuity of -0.6 logarithm of the Minimum Angle of Resolution (logMAR) or better in each eye.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Any medical condition (systemic or ophthalmic) that may preclude safe administrationof the test article.

• Use of contact lenses within 30 days of Visit 1.

• Use of contact lenses during the study.

• Participation in an investigational drug or device study within 30 days of enteringthis study.

• Other protocol-defined exclusion criteria may apply.